The increasing prevalence of sedentary work and travel has highlighted a growing health concern: the impact of prolonged inactivity on blood circulation. Turkish startup ARCH Technology is tackling this issue head-on with its ARCH V1, a wearable device that mechanically simulates the calf muscle pump, often referred to as the body's 'second heart.' The company announced today that the ARCH V1 has officially entered mass production, making its innovative solution widely available.

The ARCH V1, worn just below the knee, utilizes what the company calls "Walking Cycle Technology." This involves four micro linear actuators that generate coordinated pressure waves, mimicking the natural contraction and relaxation of calf muscles during walking. Unlike traditional compression devices or electrical stimulators, ARCH V1 focuses on mechanical replication, aiming to keep blood flowing efficiently even when the user is sitting.

The device is equipped with real-time sensors that monitor vital physiological signals such as pulse, tissue oxygenation, and edema. An on-device machine learning architecture processes this data to adapt its simulation intensity, ensuring personalized and effective circulation support. This intelligent design allows the ARCH V1 to simulate the equivalent of up to 10,000 steps per charge, or 60 cycles per minute, providing continuous support for desk workers, frequent travelers, and anyone experiencing extended periods of inactivity.

ARCH Technology previously secured funding through a successful Kickstarter campaign, demonstrating early public interest and validation for its product. The transition to mass production signals the company's readiness to scale its operations and address a broad market need. This move positions ARCH Technology as a notable player in the burgeoning wearable health technology sector, offering a distinct approach to a common modern health challenge.